Global Processing

FDA Clears Japanese Blood Pressure Drug

July 26, 2010
According to the Associated Press, Japanese drugmaker Daiichi Sankyo Inc. said that FDA regulators have approved the sale of its three-in-one high blood pressure drug Tribenzor. Daiichi Sankyo said the once-daily pill could simplify treatment for many patients. It combines three different drugs: hydrochlorothiazide, a diuretic that reduces the amount of water in the blood; amlodipine, a drug that blocks calcium from entering blood vessel walls; and olmesartan medoxomil, which blocks chemicals that can tighten blood vessels. Pfizer Inc. originally marketed Amlodipine under the name Norvasc, and Daiichi Sankyo marketed olmesartan medoxomil under the name Benicar.